Funding Received
$11.1 Million in 2 Rounds from 2 Investors
Most Recent Funding
$4.9 Million Debt Financing on May 21, 2014
Description:
Lanthio Pharma is focused on the research and development of therapeutic lantipeptide drugs for serious diseases.
Categories:
Biotechnology
Website:
http://www.lanthiopharma.com

Detailed Description

Update

Lanthio Pharma is a privately held drug discovery company that applies its proprietary lanthionine-peptide drug discovery technology LanthioPepTM for the generation of novel peptide therapeutics with increased resistance to peptidase degradation, high receptor specificity and increased intrinsic activity. Lanthio Pharma has generated stable, peptidase-resistant lanthionine peptides with highly specific agonistic activity for a number of GPCR targets, which is a focus area of the company.

Past Team (1)

Update

Funding Rounds (2) - $11.1M

Update

Investors (2)

Update
  • Ba387c343cf08b9b054b963927eac62d

    INKEF Capital

    INKEF Capital’s mission is to invest in the Netherlands in companies with the potential to...
  • 6311488f62da0de5cae9990db77ffc3e

    BioGeneration Ventures

    BioGeneration Ventures is investing in the next generation of Life Sciences companies in the...

Offices/Locations (2)

Update
  • Office

    Groningen,

    NLD

  • Office

    Nijenborgh 4

    9747 AG Groningen

    ,

    The Netherlands

Images (1)

Update
  • 00dfdc15e55ca23663bb91352d488a87